You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 2 Efficacy and safety of lenvatinib plus pembrolizumab in patients with previously treated ovarian cancer in the multicohort phase 2 LEAP-005 study

Citation Tools

Article menu

Download PDFPDF

Oral Plenary
Plenary I
IGCS20_1255
2 Efficacy and safety of lenvatinib plus pembrolizumab in patients with previously treated ovarian cancer in the multicohort phase 2 LEAP-005 study
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
González-Martín A, Chung H, Saada-Bouzid E, et al
2 Efficacy and safety of lenvatinib plus pembrolizumab in patients with previously treated ovarian cancer in the multicohort phase 2 LEAP-005 study
International Journal of Gynecologic Cancer 2020;30:A1-A2.